v3.26.1
Common Stock (Tables)
12 Months Ended
Dec. 31, 2025
Stockholders' Deficit  
Schedule of Restricted Stock Units

 

 

Number of

Units

 

 

Weighted

Average

Grant

Date Fair

Value

 

Total awards outstanding at December 31, 2023

 

 

47,665,000

 

 

$0.54

 

Units granted

 

 

-

 

 

$-

 

Units Exercised/Released

 

 

(1,500,000 )

 

$0.25

 

Units Cancelled/Forfeited

 

 

-

 

 

$-

 

Total awards outstanding at December 31, 2024

 

 

46,165,000

 

 

$0.55

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Average

 

 

 

 

 

 

Grant

 

 

 

Number of

 

 

Date Fair

 

 

 

Units

 

 

Value

 

Total awards outstanding at December 31, 2024

 

 

46,165,000

 

 

$0.55

 

Units granted

 

 

-

 

 

$-

 

Units Exercised/Released

 

 

(4,725,000 )

 

$0.24

 

Units Cancelled/Forfeited

 

 

(1,125,000 )

 

$0.99

 

Total awards outstanding at December 31, 2025

 

 

40,315,000

 

 

$0.52

 

Schedule of warrants activity

 

 

Number of

Warrants

 

 

Weighted

Average

Exercise Price

 

Total warrants outstanding at December 31, 2023

 

 

-

 

 

$-

 

Granted

 

 

412,500

 

 

$0.14

 

Exercised

 

 

-

 

 

$-

 

Cancelled/Forfeited

 

 

-

 

 

$-

 

Total warrants outstanding at December 31, 2024

 

 

412,500

 

 

$0.14

 

 

 

Number of

Warrants

 

 

Weighted

Average

Exercise Price

 

Total warrants outstanding at December 31, 2024

 

 

412,500

 

 

$0.14

 

Granted

 

 

3,484,321

 

 

$0.07

 

Exercised

 

 

-

 

 

$-

 

Cancelled/Forfeited

 

 

-

 

 

$-

 

Total warrants outstanding at December 31, 2025

 

 

3,896,821

 

 

$0.08

 

Schedule of assumptions

 

 

Year Ended

 

 

 

December 31,

 

 

 

2024

 

Exercise price

 

$0.14

 

Expected term

 

1 year

 

Expected average volatility

 

 

90.88%

Expected dividend yield

 

 

-

 

Risk-free interest rate

 

 

4.17%

 

 

Grant Date December 16,

2025

 

 

December 31,

2025

 

Exercise price

 

$0.07

 

 

$0.07

 

Expected term

 

5 years

 

 

5 years

 

Expected average volatility

 

 

104.67%

 

 

104.69%

Expected dividend yield

 

 

-

 

 

 

-

 

Risk-free interest rate

 

 

3.73%

 

 

3.73%
Schedule of fair value of the derivative liability

Initial grant date valuation (December 16, 2025)

 

$169,582

 

Change in fair value

 

 

(28,334 )

Balance at December 31, 2025

 

$141,248

 

Schedule of warrants outstanding and exercisable

Warrants Outstanding

 

 

Warrants Exercisable

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

Number Warrants

 

 

Remaining Contractual

 

 

Weighted Average

 

 

Number

 

 

Weighted Average

 

 

 

 

life (in years)

 

 

Exercise Price

 

 

of Shares

 

 

Exercise Price

 

 

412,500

 

 

 

1.00

 

 

$

0.14

 

 

 

412,500

 

 

$

0.14

 

 

3,484,321

 

 

 

4.96

 

 

$

0.07

 

 

 

3,484,321

 

 

$

0.07